Active Litigations

Cases we currently review

Free, confidential case reviews for the litigations listed below. Eligibility is always determined by an independent participating law firm.

Reviews open now

Case reviews open

Depo-Provera and Meningioma

Long-term use of the birth control shot has been linked to brain tumors called meningiomas.

A 2024 study in The BMJ reported an increased risk of meningioma with long-term use of medroxyprogesterone acetate, the active ingredient in Depo-Provera. In December 2025 the FDA approved updated labeling that warns about meningioma. Federal lawsuits have been consolidated in MDL 3140 in the Northern District of Florida. Women who received Depo-Provera injections and were later diagnosed with a meningioma may qualify.

Check if I may qualify

On the horizon

Case reviews opening soon

Leave your email on any case below and we will let you know the moment reviews open. One email per case, nothing else.

Opening soon

67,000+Pending federal cases

Talcum Powder and Ovarian Cancer

Long-term use of talc-based powder products may have contributed to ovarian cancer.

Opening soon

11,000+Pending federal cases

Chemical Hair Relaxers

Long-term use of chemical hair relaxers is alleged to be linked to uterine and ovarian cancer.

Opening soon

BellwetherTrials anticipated 2026

Paragard IUD

The copper Paragard IUD is alleged to break during removal, leaving fragments behind.

Opening soon

Fastest growingFederal MDL docket

GLP-1 Weight Loss Medications

Manufacturers of Ozempic, Wegovy, and Mounjaro are alleged to have failed to warn about severe gastrointestinal injuries.

Free

Case reviews cost nothing. Participating law firms work on contingency.

Confidential

Your information stays between you, the specialist, and the reviewing law firm.

About 60 seconds

A short questionnaire is all it takes to see if you may qualify.

See how the review process works

Attorney Advertising

LegalWisdom is a legal advertising service, not a law firm. Prior results do not guarantee a similar outcome.